A. Vlahiotis

发表

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

Edward L Spitznagel, R. Govindan, E. Spitznagel, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comorbidity in patients with cancer of the head and neck: Prevalence and impact on treatment and prognosis

J. Piccirillo, A. Vlahiotis, 2006, Current oncology reports.

The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship

D. Price, G. Colice, C. Ambrose, 2017, Pragmatic and observational research.

Real-World Therapy Management and Outcomes of First-Line Axitinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma in the United States

Y. Zakharia, A. Vlahiotis, R. Levin, 2022, Frontiers in Oncology.

HLA alleles determine differences in human natural killer cell responsiveness and potency

J. Piccirillo, M. Colonna, M. Cella, 2008, Proceedings of the National Academy of Sciences.

Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practices.

M. Fisher, K. DeBusk, G. Vidal, 2021, Future oncology.

Prognostic impact of comorbidity in patients with bladder cancer.

A. Kibel, J. Piccirillo, M. Radwan, 2008, European urology.

The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis.

J. Piccirillo, M. Kramper, S. Thawley, 2009, Archives of otolaryngology--head & neck surgery.

General patient factors

J. Piccirillo, A. Vlahiotis, 2005 .

Clinical Outcomes of Chronic Rhinosinusitis in Response to Medical Therapy: Results of a Prospective Study

R. Levitt, J. Piccirillo, M. Kramper, 2007, American journal of rhinology.

Relief of idiopathic subjective tinnitus: is gabapentin effective?

E. Spitznagel, J. Piccirillo, R. Chole, 2007, Archives of otolaryngology--head & neck surgery.

Gender Differences in Self-Reported Symptom Awareness and Perceived Ability to Manage Therapy with Disease-Modifying Medication Among Commercially Insured Multiple Sclerosis Patients

T. Burroughs, E. Cox, A. Vlahiotis, 2010, Journal of managed care pharmacy : JMCP.

Commercial Claims Costs Related to Healthcare Resource Use Associated With a Diagnosis of Peanut Allergy.

M. Greenhawt, T. Green, M. Shaker, 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

The changing prevalence of comorbidity across the age spectrum.

E. Steyerberg, E. Spitznagel, J. Piccirillo, 2008, Critical reviews in oncology/hematology.

Treatment Patterns, Resource Utilization And Costs In Muscular Dystrophy Patients: Analysis Using Administrative Claims Data.

M. Stott-Miller, A. Vlahiotis, L. Palmer, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Treatment Patterns and Costs of Transfusion and Chelation in Commercially-Insured and Medicaid Patients with Transfusion-Dependent β-Thalassemia

A. Vlahiotis, K. Cappell, C. Paramore, 2017 .

Impact Of The Patient Protection And Affordable Care Act Contraceptive Coverage Mandate On Utilization Of Refillable And Long-Acting Reversible Contraceptives

Reethi N Iyengar, A. Vlahiotis, Y. Tian, 2015 .

A comparison of treatment patterns, healthcare resource utilization, and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the US

P. Juneau, A. Cole, A. Vlahiotis, 2018, Journal of medical economics.

Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma.

P. Humphrey, A. Kibel, J. Piccirillo, 2008, Urology.

Association Between Switching to a High-Deductible Health Plan and Discontinuation of Type 2 Diabetes Treatment

A. Fendrick, M. Chernew, S. Rajpathak, 2019, JAMA network open.

Discontinuation Rates and Health Care Costs in Adult Patients Starting Generic Versus Brand SSRI or SNRI Antidepressants in Commercial Health Plans

A. Vlahiotis, S. Devine, Jeff Eichholz, 2011, Journal of managed care pharmacy : JMCP.